期刊论文详细信息
BMC Cancer
Inflammatory biomarker score and cancer: A population-based prospective cohort study
Research Article
Adetunji T. Toriola1  Leavitt Morrison1  Jussi Kauhanen2  Kimmo Ronkainen2  Sudhir Kurl2  Jari A. Laukkanen3 
[1] Department of Surgery, Division of Public Health Sciences, and Siteman Cancer Center, Washington University School of Medicine, 63144, St Louis, MO, USA;Institute of Public Health and Clinical Nutrition, University of Eastern Finland, 70211, Kuopio, Finland;Institute of Public Health and Clinical Nutrition, University of Eastern Finland, 70211, Kuopio, Finland;Department of Internal Medicine, Lapland Central Hospital, 96300, Rovaniemi, Finland;
关键词: Biomarkers;    c-reactive protein;    Inflammation;    Leukocyte count;    Cancer mortality;   
DOI  :  10.1186/s12885-016-2115-6
 received in 2015-11-03, accepted in 2016-02-03,  发布年份 2016
来源: Springer
PDF
【 摘 要 】

BackgroundInflammation is associated with cancer but there are conflicting reports on associations of biomarkers of inflammation with cancer risk and mortality. We investigated the associations of C-reactive protein (CRP) and leukocyte count with cancer risk and mortality using individual biomarkers, and an inflammatory score derived from both biomarkers.MethodsWe conducted this analysis among 2,570 men enrolled in the population-based, prospective Kuopio Ischemic Heart Disease Risk Factor Study in Finland. During an average follow-up period of 26 years, 653 cancer cases and 287 cancer deaths occurred. We computed a z-score for each participant, with the combined z-score being the sum of each individual’s CRP and leukocyte z-scores. Multivariable-adjusted Cox proportional hazard model was used to evaluate associations with cancer risk and mortality.ResultsUsing individual biomarkers, elevated leukocyte count was associated with an increased risk of cancer (RR = 1.31, 95 % CI 1.04-1.66), and cancer mortality (RR=, 95 % CI 1.39, 0.98-1.97). The corresponding results for CRP were (RR = 1.23, 95 % CI 0.97-1.55) for risk and (RR = 1.15, 95 % CI 0.81-1.64) for cancer mortality. Associations of the biomarkers with cancer appeared to be more robust using the combined z-score. HRs comparing men within the highest z-score quartile to those within the lowest z-score quartiles were 1.47 (95 % CI 1.16-1.88, p-trend < 0.01) for cancer risk, and 1.48 (95 % CI 1.03-2.14, p-trend = 0.09) for cancer mortality.ConclusionOur study suggests that inflammation is associated with cancer risk and mortality, and combining inflammatory biomarkers into a score is a robust method of elucidating this association.

【 授权许可】

CC BY   
© Morrison et al. 2016

【 预 览 】
附件列表
Files Size Format View
RO202311102753547ZK.pdf 433KB PDF download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  文献评价指标  
  下载次数:18次 浏览次数:0次